Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
PB Ratio: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Price-to-book ratio
Latest
1.92
↓ 45% below average
Average (9y)
3.48
Historical baseline
Range
High:7.56
Low:1.71
CAGR
-10.8%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1.92 | +12.3% |
| 2023 | 1.71 | -20.7% |
| 2022 | 2.16 | +13.8% |
| 2021 | 1.90 | +6.8% |
| 2020 | 1.78 | -14.9% |
| 2019 | 2.09 | -45.2% |
| 2018 | 3.81 | -49.6% |
| 2017 | 7.56 | +16.1% |
| 2016 | 6.51 | +21.3% |
| 2015 | 5.37 | - |